22.692 articles found

Diagnosis and treatment of common forms of tremor.

Puschmann A, Wszolek ZK.

Semin Neurol · 2011-02-14

DOI: 10.1055/s-0031-1271312PMID: 21321834

New non-oral drug delivery systems for Parkinson's disease treatment.

Md S, Haque S, Sahni JK, Baboota S, Ali J.

Expert Opin Drug Deliv · 2011-02-12

DOI: 10.1517/17425247.2011.556616PMID: 21314492

IVIG MODULATION OF CHEMOKINES FOR TREATMENT OF MULTIPLE SCLEROSIS, ALZHEIMER'S DISEASE, AND PARKINSON'S DISEASE

REIPERT BIRGIT, EHRLICH HARTMUT, SCHWARZ HANS-PETER, ELOVAARA IRINA.

· 2011-02-11

A stable producer cell line for the manufacture of a lentiviral vector for gene therapy of Parkinson's disease.

Stewart HJ, Fong-Wong L, Strickland I, Chipchase D, Kelleher M, Stevenson L, Thoree V, McCarthy J, Ralph GS, Mitrophanous KA, Radcliffe PA.

Hum Gene Ther · 2011-02-10

DOI: 10.1089/hum.2010.142PMID: 21070114

Treatment of advanced Parkinson's disease.

Varanese S, Birnbaum Z, Rossi R, Di Rocco A.

Parkinsons Dis · 2011-02-07

DOI: 10.4061/2010/480260PMID: 21331376

Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients.

Gil RA, Hwynn N, Fabian T, Joseph S, Fernandez HH.

Parkinsonism Relat Disord · 2011-02-05

DOI: 10.1016/j.parkreldis.2011.01.007PMID: 21296606

Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.

Danielyan L, Schäfer R, von Ameln-Mayerhofer A, Bernhard F, Verleysdonk S, Buadze M, Lourhmati A, Klopfer T, Schaumann F, Schmid B, Koehle C, Proksch B, Weissert R, Reichardt HM, van den Brandt J, Buniatian GH, Schwab M, Gleiter CH, Frey WH.

Rejuvenation Res · 2011-02-03

DOI: 10.1089/rej.2010.1130PMID: 21291297

Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment.

Johansson C, Ballard C, Hansson O, Palmqvist S, Minthon L, Aarsland D, Londos E.

Int J Geriatr Psychiatry · 2011-02-01

DOI: 10.1002/gps.2516PMID: 20665553

Up-regulation of endoplasmic reticulum stress-related genes during the early phase of treatment of cultured cortical neurons by the proteasomal inhibitor lactacystin.

Choy MS, Chen MJ, Manikandan J, Peng ZF, Jenner AM, Melendez AJ, Cheung NS.

J Cell Physiol · 2011-02-01

DOI: 10.1002/jcp.22359PMID: 20683911

Effect of low-frequency repetitive transcranial magnetic stimulation combined with physical therapy on L-dopa-induced painful off-period dystonia in Parkinson's disease.

Kodama M, Kasahara T, Hyodo M, Aono K, Sugaya M, Koyama Y, Hanayama K, Masakado Y.

Am J Phys Med Rehabil · 2011-02-01

DOI: 10.1097/phm.0b013e3181fc7ccdPMID: 20975525

The role of apolipoprotein E polymorphisms in levodopa-induced dyskinesia.

Molchadski I, Korczyn AD, Cohen OS, Katzav A, Nitzan Z, Chapman J, Hassin-Baer S.

Acta Neurol Scand · 2011-02-01

DOI: 10.1111/j.1600-0404.2010.01352.xPMID: 21108621

Dopamine agonists in the treatment of prolactinoma: are they still first choice?

Ogilvie CM, Milsom SR.

Intern Med J · 2011-02-01

DOI: 10.1111/j.1445-5994.2010.02410.xPMID: 21138511